0 47

Cited 0 times in

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer - Authors' reply

DC Field Value Language
dc.contributor.author이충근-
dc.contributor.author최혜진-
dc.date.accessioned2024-03-22T06:18:26Z-
dc.date.available2024-03-22T06:18:26Z-
dc.date.issued2023-03-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/198512-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfLANCET GASTROENTEROLOGY & HEPATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAntineoplastic Agents, Immunological* / therapeutic use-
dc.subject.MESHBiliary Tract Neoplasms* / drug therapy-
dc.subject.MESHHumans-
dc.subject.MESHReceptor, ErbB-2-
dc.subject.MESHTrastuzumab / therapeutic use-
dc.titleTrastuzumab plus FOLFOX for HER2-positive biliary tract cancer - Authors' reply-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorChoong-Kun Lee-
dc.contributor.googleauthorHye Jin Choi-
dc.identifier.doi10.1016/S2468-1253(23)00006-7-
dc.contributor.localIdA03259-
dc.contributor.localIdA04219-
dc.relation.journalcodeJ03941-
dc.identifier.eissn2468-1253-
dc.identifier.pmid36773613-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S2468125323000067-
dc.contributor.alternativeNameLee, Choong-kun-
dc.contributor.affiliatedAuthor이충근-
dc.contributor.affiliatedAuthor최혜진-
dc.citation.volume8-
dc.citation.number3-
dc.citation.startPage211-
dc.citation.endPage212-
dc.identifier.bibliographicCitationLANCET GASTROENTEROLOGY & HEPATOLOGY, Vol.8(3) : 211-212, 2023-03-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.